ISPE Annual Meeting 29 October 1 November 2017 San Diego, CA. Need systems approach to pharmaceutical manufacturing

Similar documents
Quality Metrics: A Regulatory Perspective

Future of Pharmaceutical Quality and the Path to Get There

IVT Laboratory Week Jerry Lanese. Ph.D. The Lanese Group, Inc The Lanese Group, Inc.

Guidance for Industry Quality Systems Approach to Pharmaceutical Current Good Manufacturing Practice Regulations

Guidance for Industry

The Impact of Quality Culture on Quality Risk Management. FDA Perspective on Quality Culture; how it Impacts Risk Management

The Future of Pharmaceutical Quality

Q10 PHARMACEUTICAL QUALITY SYSTEM

FDA Quality Metrics, Data Integrity and Application of Statistics Throughout Process Validation in a Global Economy

Effective Risk Management A Catalyst For Quality Performance

Lean Enterprise Achieving efficiency in a world demanding effectiveness

Largest Independent Pharmaceutical Benchmarking Survey

Analysis of the Implementation of Total Productive Maintenance, Total Quality Management, and Just-In-Time in Pharmaceutical Manufacturing

Enabling Improvement through the Product Lifecycle: Change Management within a PQS

Performance Management, Balanced Scorecards and Business Intelligence: Alignment for Business Results

Extending Lean Initiatives Across the Organization:

USING OPERATIONAL EXCELLENCE (OPEX) AND LEAN MANAGEMENT TO IMPROVE ORGANIZATIONAL INTELLIGENCE

More than 2000 organizations use our ERM solution

Culture Change. Sustaining a Lean Enterprise Transformation? Presented by Industrial Solutions, Inc

ICH Q8/Q8(R)

QUALITY MANAGEMENT SYSTEM 8/30/2017

A Guide to the. Incorporating the Essential Elements of Strategy Within Your Organization. Empower

Visionary Leadership. Systems Perspective. Student-Centered Excellence

Service Differentiation: Your 3-Step Plan. Differentiation, Service DNA, and Continuous Improvement in Field Service

Outsourcing - managing risks and opportunities over which you now have less control

6 Steps to Effective Supplier Quality Audits. A Guide For Medical Device Companies

Lean Gold Certification Blueprint

CORE VALUES AND CONCEPTS

Quadrant I. Module 25: Balanced Scorecard

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf

Banishing Waste and Delivering Value in Your BCM Program

added Fine-tune your balanced scorecard and make it a machine geared toward continuous improvement by Alex Fedotowsky

2. Risk-based compliance was also a key component in the FDA's new approach for dealing with electronic records and signatures: 21 CFR Part 11.

Quality Systems Frameworks. RIT Software Engineering

Can Quality Solve the Equation?

POSITION DESCRIPTION Property Operations Manager

Guidance for Industry

GMP Challenges to Global Pharma Companies

Agile Projects 7. Agile Project Management 21

Pharmaceutical Quality for 21 st Century Initiative

B Y D A N D E N E H Y

Quality in Global Sourcing

New Development Bank Information Technology Policy

An Introduction to Strategic Planning for Service Organizations

Oursourcing and Supplier Qualification from the perspective of the pharmaceutical Industry

FOSTERING A CULTURE OF QUALITY

When cost cutting alone isn t enough

Achieving Operational Excellence in Pharma & Biotech Adapting best practice to meet the unique characteristics of the industry

Core Values and Concepts

Is your operational risk management helping execute your strategy?

Historical Phases of Production

Practice at UVa. & Chief Financial Officer

PART 1: INTRODUCTION. Purpose of the BIZBOK Guide. What is Business Architecture?

RESULTS. SAMPLE OF AN ACTUAL REPORT (PART II) Name of site left off. CERTIFIED: No Yes

Modernizing Pharmaceutical Quality Systems; Studying Quality Metrics and Quality Culture;

Agile Essentials Track: Business Services

ICH Q10/WHO TRS A Regulatory Perspective

Performance Measurement for Organizational Improvement

Project Management Assessment. Apply an In-Depth Approach to Project Management to Achieve Systematic Success

THE CULTURE CANVAS A Working Guide and Checklist to Support the Development of a High-Performing Culture

CHAPTER 4 PRODUCT DEVELOPMENT LIFE CYCLE

FDA s Role in Vaccine Supply

Welcome to Coral Springs. From Bean Field to Baldrige: Lessons Learned From One City s Journey

SKF Manufacturing Excellence. Kent Viitanen Director, Industrial Division Manufacturing & Supply

Asset management Overview, principles and terminology

Insights into the St.Gallen OPEX and Quality Metrics Research

A Holistic Framework for Business Excellence

Core Values and Concepts

The Strategic Management Maturity Model. Eight Dimensions of Strategic Management

Driving effective quality governance using Quality Metrics

The Strategic Management Maturity Model. Eight Dimensions of Strategic Management

CENTRAL PROCESS REPOSITORY

INTEGRITY MANAGEMENT CONTINUOUS IMPROVEMENT. Foundation for an Effective Safety Culture

ORGANIZATIONAL STRATEGY AND ALIGNMENT FOR CUSTOMER EXPERIENCE MANAGEMENT

The Drug Industry at a Crossroad: PAT s Role

GLP Compliance Assurance vs. Quality Assurance. Quality Beyond GLP Compliance

Breakout Session A. Asset Management Best Practices and What Trends You Should Know (ISO 55000: Asset Management)

A conversation about the framework for performance excellence PERFORM LIKE A ROCK STAR!

PHMSA Update Safety Management Systems

Learning Objectives. System-Based Thinking as Related to Systems-Based Inspections and Audits

Business Process Management Introduction. Marek Zborowski PhD.

Request for Quality Metrics Guidance for Industry

Ensuring BD Success With Metrics-Based Management

The COSO Risk Framework: A reference for internal control? Transition from COSO I to COSO II

Strategy Maps and the Balanced Scorecard. Don Breckenridge Jr. President

QUALITY MANAGEMENT IN THE BOARD ROOM

The Economics of CMMI

IMPACT MEASUREMENT METHODOLOGY

Proposed International Standard on Auditing 315 (Revised)

What is ITIL 4. Contents

ETA Sector Strategies Technical Assistance Initiative Self-Assessment Pilot Tool 2.0

Risk Based Validation. Why, How and with what tools?

Risk Management in the 21 st Century Ameren Business Risk Management

Ensuring An Effective Quality System. M. Kowolenko, Ph.D. SVP, Biopharmaceutical Operations & Technology

Voluntary Pilot Meeting Preview: How will CDRH apply assessments in the voluntary program?

PDA Comments ICH Q10; Pharmaceutical Quality System October Suggested Revision

TOTAL PERFORMANCE SCORECARD

The Business Case for a Project and Portfolio Management Platform. Craig McQueen Agora Consulting Partners Inc.

While the recognition

Transcription:

Aligning Quality Excellence with ICH(Quality Systems Management) Prabir K Basu Need systems approach to pharmaceutical manufacturing Pharmaceutical manufacturing needs to be approached as a system that regards the organization as comprising of three purposefully designed parts that are interconnected viz. input, process and output. A systems approach makes an organization to function as a unit despite being a complex entity that's subject to changes from within and outside. This approach allows analysis of problems in a systematic fashion identifying the factors affecting the system and its various components thus allowing the design of proactive solutions to overcome problems and reduce risks to the operation and product quality. Pharmaceutical manufacturing is a system which has a set of parts that interact and affect each other, thereby creating a larger whole of a complex thing. Pharmaceutical manufacturing is complex and is growing more complex everyday with globalization globalization often brings uncontrollable risks to supply as well as quality. The old ways are inadequate for our dynamic world. Systems thinking will allow a model of decision making that will help pharma manufacturing effectively deal with changes and adapt. A maximally efficient, agile, flexible pharmaceutical manufacturing sector that reliably produces high quality drug products without extensive regulatory oversight Dr. Woodcock, 2005 Prabir K Basu 1

Lack of a systems approach to CGMP makes it difficult to comply GMPs provide guidance on the manufacture and control of pharmaceutical product, but GMPs do not address the systems needed to bring a quality product to market The guidance provided by GMPs is mostly on how to address problems after the fact, such as CAPA, change control, etc. but do not profess proactive continual improvement GMPs, as it is, provide a discrete set of instructions that involve many actors and many independent systems it is difficult to see the big picture without a proper systems approach. GMPs do not drive a lifecycle approach to quality and there is no concept of continuous improvement in GMPs Issues where an action impacts (or is affected by) the environment surrounding the issue (including people, equipment, culture, etc.), cannot be solved without a systems approach. This is particularly important in this global environment. GMPs only touch on management responsibility and employee participation in quality. There is no specific reference in the GMPs on the necessity of a robust quality culture in an organization Without a systems approach, problems reoccur and are made worse by past attempts to fix them. Systems thinking would allow people to make their understanding of GMPs more explicit in a manner similar to how engineers use engineering principles to analyze and improve their understanding of mechanical systems. Prabir K Basu 3 FDA Industry effort to implement a Quality Systems Approach to cgmp Regulation since early 2000 GMPs originated in 1970s and have been only incrementally added to. The ISO Quality Management thinking was not embedded in the GMPs. In 2002, FDA issued a report titled Pharmaceutical CGMPs for the 21st century a Risk Based Approach In 2006, the US Food and Drug Administration issued a document entitled, Guidance for Industry: Quality Systems Approach to Pharmaceutical Current Good Manufacturing Practice Regulations. This document represented FDA s efforts to encourage the pharmaceutical and biotechnology industry to adopt...modern quality systems and risk management approaches... to management of GMP compliance. The idea was that a system of management controls can serve to support and maintain a company s GMP compliance status. The establishment of management controls is a concept that is embodied in the FDA guidance and has also been advanced by FDA in other contexts in recent years. Since then, there has been multiple FDA Industry efforts to implement Quality Systems approach to pharma manufacturing 2

Lawrence Yu, CDER Update: Quality Metrics, Quality Culture, and other Initiatives, 15th ANNUAL PIA PR REGULATORY CONFERENCE Innovation and Compliance as an Enabler of Quality System Robustness, JUNE 22, 2017, Ritz Carlton Hotel San Juan PR My goal today is to show that CDER s Quality Journey is synergistic with the evolution of the OPEX model at St. Gallen s Around 2004 2006, the OPEX team in Switzerland, along with its industry collaborators independently embarked upon developing a systems approach to manufacturing and quality in pharma St.Gallen Operational Excellence Model provides analysis of pharma manufacturing based on a systems approach 3

The St. Gallen OPEX Model is a Total Quality Management System OPEX model comprises of sub systems that are critical and they reinforce each other TPM represents equipment effectiveness and overall efficiency of a comprehensive productive maintenance system TQM represents the rigorous problem solving process which should be in an operation where Total Quality and Continuous Improvement are key objectives. Six Sigma and Lean approaches are very much aligned to this concept. JIT represents optimization of manufacturing operations and ultimate customer satisfaction. It is one of the key elements of Total Quality Management and is possible only when good processes, systems and a culture of continuous improvement is in place. Management System incorporates other key elements of Total Quality Management such as management commitment, employee participation, continuous improvement and training. St. Gallen OPEX framework contains different blocks How efficiently fixed assets are being managed while effectively using new process technology? The TQM System is a measure of quality performance (e.g. reduce variability, scrap rates, complaint rates etc.). TPM TQM JIT 1 2 3 Foundation The main objective of the foundation elements is to support the deployment of TQM, TPM and JIT principles. Elements Effective Management System Enablers Prabir K Basu The main objective of JIT is the reduction of working capital (incl. inventories) by simultaneously increasing service levels. The main objective of an effective Management System is a learning organization that is managed by clear objectives. 8 4

St. Gallen OPEX Framework enables continuous improvement Preventive maintenance Stabilize the Underlying System TPM Process management TQM Customer integration Cross funct. Effective Supplier Planning Housekeeping product Layoutoptimization technology quality adherence development usage management Standardized Standardized Standardized equipment processes replenishment Stable running machines Stable processes Low inventory 1 2 3 Self directed High continuous Low abseentism teams improvement rates & fluctuation Effective Management System Set up time reductions Low absenteeism & fluctuation Direction setting Management commitment and company culture Employee involvement & continuous improvement Functional integration & qualification Manage the Flow & Reduction of Waste JIT Pull system Flexible workforce Operational Performance Continuous Improvement Management & Leadership Source: University of St.Gallen Operational Excellence (OPEX) and Quality management have similar objectives The ultimate objectives of both OPEX and Quality are to reduce variation, streamline operations, minimize chances of errors and thus achieve a State of Control and manage the risks of noncompliance and wasteful operations. Risk management (ICH Q9) can be defined as the identification, assessment, and prioritization of risks to minimize uncertainty in processes, operations and ultimately quality. Project prioritization activity should be both cost and risk driven both are really the same in fact, risk to quality should have a priority over cost to prevent quality deterioration. In order to implement a risk informed decision making approach, risk management activities should be embedded into organizational structures and processes at both the operational and strategic levels. Prabir K Basu 10 5

Similarities between OPEX and Quality Management programs System based approach with focus on establishing effective systems Both attempt to standardize systems to increase reliability. Both aim to develop closed loop processes that enable continuous improvement. Proactive risk management that goes beyond compliance. Generating actionable data from key performance indicators (KPIs). Performance measurement is key to success in both programs. Collaboration among cross functional teams. Management commitment and employee participation is key in both programs. Requires documentation and knowledge management OPEX approach can be a measure of a robust Quality System Operational Excellence (OPEX) efforts are generally aimed as business goals which seek to reduce inefficiencies and increase quality. They have all the elements of an effective quality system built in. OPEX is a process that involves taking care of customers' needs, keeping the employees motivated and empowered, and continually improving the current activities at the workplace. The important components of a true operational excellence program (OPEX) are striving for stable operations, minimizing variations, continuous improvement, management commitment, and employee participation. These are also key components of any successful Quality Management program. Therefore, one should be able to use similar metrics for OPEX implementation and Quality in a pharmaceutical plant Prabir K Basu 12 6

The OPEX framework incorporates and has the ability to measure the core elements of Quality Management Quality Management Requires: Systems and Techniques formal system of operations and quality management should be in place Processes Analysis of processes and continuous improvement is a focus. Look after the process and the product looks after itself. (Hutchins, 1990) Management This is a way of life for a company and management must be committed and lead the effort People ongoing education and training supports drive to quality and efficiency. Employees must be encouraged to take responsibility and communicate effectively Teamwork everyone works individually and as a team Culture a radical change in culture and way of work in an organization Metrics built into the model allowing actionable responses OPEX captures performance relative to a standard, allows and encourages comparison, and supports a Quality Operations Excellence strategy. Prabir K Basu 13 Common Architecture for Quality Management & Operational Excellence Operational/Quality Management/Excellence (Quality & Cost) Stable Operations Continuous Improvement Facilities & Equipment Quality Systems Personnel Development Knowledge Management Commitment Employee Participation Technology Prabir K Basu 14 7

These are also the chapters of an important document issued by the FDA in the last decade Chapter 1: Pharmaceutical Quality System Chapter 2: Management Responsibilities Chapter 3: Continual Improvement of Process Performance and Product Quality Chapter 4: Continual Improvement of the Pharmaceutical Quality System Chapter 5 : Glossary Which is this document? Prabir K Basu 15 Guidance for Industry Q10 Pharmaceutical Quality System Additional copies are available from: Office of Communication Division of Drug Information Center for Drug Evaluation and Research Food and Drug Administration 10903 New Hampshire Ave.,Bldg. 51, Room 2201 Silver Spring, MD 20993-0002 (Tel) 301-796-3400 http://www.fda.gov/cder/guidance/index.htm Office of Communication, Outreach and Development, HFM-40 Center for Biologics Evaluation and Research Food and Drug Administration 1401 Rockville Pike, Rockville, MD 20852-1448 (Tel) 1-800-835-4709 or 301-827-1800 http://www.fda.gov/cber/guidelines.htm. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) April 2009 ICH 8

Vision of ICH Q10 Quality Systems Develop a harmonized pharmaceutical quality system applicable across the lifecycle of the product emphasizing an integrated approach to quality risk management and science. (Brussels July 2003) ICH Q10 describes one comprehensive model for an effective pharmaceutical quality system. (ICH Q10) Prabir K Basu 17 Key Elements of Q10 Q10 emphasizes systems approach to Quality Management by establishing and maintaining a state of control and continuous improvement as key elements as is in any systems approach to process/operations management Q10 is based on a set of stated Objectives, supported by specified Enablers which support continual improvement of product quality and the Quality System itself. It relies heavily on the concept of Management Responsibility and Employee Participation for the Quality Systems 9

Pharmaceutical Quality System(ICH Q 10) Achieve Product Realization Establish & Maintain State of Control Facilitate Continual Improvement Stable Operations Stable Processes Quality Assurance Management Committment (Effective Management System) Knowledge Management (Prevention not Reaction) Quality Risk Management (Prioritization based not just on cost but also on risk) Prabir K Basu 10

ICH Q10 and Pharmaceutical Quality Systems were designed to address the gap in systems approach to GMPs Regulatory agencies and the pharmaceutical industry recognized this deficiency in approach to cgmps and thus in the recent years have proposed a systems approach to the cgmps. The overarching philosophy articulated in both the CGMP regulations and in robust modern quality systems is: Quality should be built into the product, and testing alone cannot be relied on to ensure product quality. Quality Systems Approach to Pharmaceutical CGMP Regulations, FDA, 2006 ICH Q10 aims to promote a paradigm shift from discrete GMP compliance procedures at each stage of the product lifecycle to a comprehensive quality systems approach over the lifecycle of the product Neil Wilkinson, ICH Q10 Pharmaceutical Quality System WCC PDA Dinner Meeting, Jan 2012 What is missing? Measuring Quality or Metrics A systems approach cannot be effective without an appropriate way to measure performance and continually improve Prabir K Basu 21 We need an integrated OPEX, Quality Systems Management, and EHS program Most companies use different teams and programs for OPEX, Quality, Quality Systems, EHS etc. Each group is trying to implement their own systems and measure performance in separate efforts These programs should be integrated into one and there should be a unified framework or system for all these programs. In addition to cost savings, quality and safety goals also can be achieved by an overall systems management and overall performance tracking and management system. FDA and industry are debating Quality Metrics. Why duplicate efforts? Determine how to measure the overall pharmaceutical Operations system and that will provide metrics for quality and safety also With minor adjustments to the work that St. Gallen is doing, we can make it s model acceptable to both the regulatory agencies and the industry. All the basic elements are already there in the OPEX model, and Quality Metrics is embedded in the already existing Operational Excellence programs of many pharmaceutical companiesaround theworld. Prabir K Basu 22 11

Pharmaceutical Production System Model The new Pharmaceutical Production System Model (PPSM) proposed by St. Gallen combines both OPEX and Quality Management goals. It was developed specifically for the FDA Quality Metrics Project. The model enables a structured analysis of the components of a Pharmaceutical Quality system. The St.Gallen OPEX Model as Basis for the PPSM A System Approach to Pharmaceutical Manufacturing TPM: Total Preventive Maintenance; TQM: Total Quality Management; JIT: Just in Time; PQS: Pharmaceutical Quality System 24 12

PPSM is a successful attempt to represent suitable metrics for the Pharmaceutical Quality System Human beings adjust behavior based on the metrics they're held against. Anything you measure will impel a person to optimize his score on that metric. What you measure is what you'll get. 1 Perhaps what you measure is what you get. More likely, what you measure is all you ll get. What you don t (or can t) measure is lost H. Thomas Johnson Thus the discrete metrics recommended in revised FDA Draft Guidance for Quality Metrics (2016) has obvious limitations. These are also inherently lagging indicators and do not reflect the effectiveness and efficiency of the quality systems. An effective performance measurement system should provide timely, accurate feedback on the efficiency and effectiveness of operations. 2 A Pharmaceutical Quality System is successful when it assures an ongoing state of control. 3 PPSM provides a structured and holistic depiction of the relevant data from the St. Gallen OPEX database which truly reflects the efficiency and the efficiency of the pharmaceutical operations/quality system. In addition, it also positions the three metrics, suggested in the revised FDA Draft Guidance (2016) within the broader context of holistic understanding. 3 Food & Drug Administration, Quality System (Drugs), http://www.fda.gov/drugs/developmentapprovalprocess/manufacturing/ucm278584.htm 1 https://hbr.org/2010/06/column you are what you measure 2 Kaplan, R., & Norton, D. (1993, September/October ). Putting the balanced scorecard to work. Harvard Business Review, pp. 134 142. Summary Pursuing operational excellence is both a challenge and a commitment. But for operations, willing to take it on, the result is improved performance across a range of outcomes, including product quality, safety, and ultimately, financial performance. Operational excellence is a journey, not a destination. It s also an iterative, cross functionalprocess bynature,involvingmultipledepartments,processes and stakeholders. Creating silos of quality, EHS, operations management creates roadblocks to achieving operational excellence, while an integrated system streamlines the path forward. ThesameistrueforFDA sapproaches. Individual approaches such as Quality by Design, PAT, ICH, Quality Metrics, etc. create more confusion among companies. They sometimes worry, what s next? Perhaps, if we wait long enough a new approach will be there? Operational excellence provides an unique opportunity and format to combine all of these diverse efforts into one and make it very effective and easy to adopt. 13